Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Working Capital Changes: 2019-2024

Historic Other Working Capital Changes for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to -$46.7 million.

  • LifeStance Health's Other Working Capital Changes fell 92.49% to -$12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.7 million, marking a year-over-year decrease of 868.86%. This contributed to the annual value of -$46.7 million for FY2024, which is 2444.89% down from last year.
  • According to the latest figures from FY2024, LifeStance Health's Other Working Capital Changes is -$46.7 million, which was down 2444.89% from -$37.6 million recorded in FY2023.
  • LifeStance Health's Other Working Capital Changes' 5-year high stood at $29.1 million during FY2021, with a 5-year trough of -$46.7 million in FY2024.
  • For the 4-year period, LifeStance Health's Other Working Capital Changes averaged around -$17.1 million, with its median value being -$25.4 million (2022).
  • As far as peak fluctuations go, LifeStance Health's Other Working Capital Changes crashed by 18524.57% in 2023, and later crashed by 2444.89% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Other Working Capital Changes stood at $29.1 million in 2021, then crashed by 145.22% to -$13.2 million in 2022, then plummeted by 185.25% to -$37.6 million in 2023, then decreased by 24.45% to -$46.7 million in 2024.
  • Its Other Working Capital Changes was -$46.7 million in FY2024, compared to -$37.6 million in FY2023 and -$13.2 million in FY2022.